CAPTRUST Financial Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,136	Closed	-$226K	–	2833
2023 Q3	$226K	Buy	1,136 +306	+37%	+$72.4K	﹤0.01%	2206
2023 Q2	$237K	Buy	+830	New	+$230K	﹤0.01%	2142
2022 Q3	–	Sell	-1,324	Closed	-$253K	–	4300
2022 Q2	$253K	Buy	1,324 +128	+11%	+$22.6K	﹤0.01%	1531
2022 Q1	$248K	Buy	1,196 +902	+307%	+$149K	﹤0.01%	1575
2021 Q4	$52K	Sell	294 -20	-6%	-$3.94K	﹤0.01%	2641
2021 Q3	$65K	Buy	314 +7	+2%	+$1.37K	﹤0.01%	2411
2021 Q2	$58K	Sell	307 -331	-52%	-$54.2K	﹤0.01%	2426
2021 Q1	$83K	Buy	+638	New	+$76.5K	﹤0.01%	2089
2020 Q3	–	Sell	-100	Closed	-$5K	–	3282
2020 Q2	$5K	Buy	+100	New	+$4.12K	﹤0.01%	2407
2019 Q4	–	Sell	-250	Closed	-$7K	–	1884
2019 Q3	$7K	Hold	250	–	–	﹤0.01%	1607
2019 Q2	$14K	Buy	+250	New	+$12.1K	﹤0.01%	1410

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAPTRUST Financial Advisors's SWAV Position: Q4 2023 in Review

CAPTRUST Financial Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 1,136 shares — an estimated $226K sold.

CAPTRUST Financial Advisors first reported a position in SWAV in Q2 2019 and held it in 11 quarters. The position peaked at $253K in Q2 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

CAPTRUST Financial Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
CAPTRUST Financial Advisors sold 1,136 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $226K.
CAPTRUST Financial Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 11 quarters.
CAPTRUST Financial Advisors's Shockwave Medical, Inc. Common Stock position peaked at $253K in Q2 2022.
427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.